Allouche Cyril

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2019-03-19	2019-03-18	Revance Therapeutics Inc (RVNC)	PlS Planned sale	91,721 +7.7% 148.66 US$1,463,411	91,721 +7.7%	148.66	US$1,463,411
2019-01-23	2019-01-22	Revance Therapeutics Inc (RVNC)	PlS Planned sale	72,286 +35.6% 258.47 US$336,286	72,286 +35.6%	258.47	US$336,286
2019-01-04	2019-01-03	Revance Therapeutics Inc (RVNC)	PlS Planned sale	92,537 +3.7% 97.92 US$4,895,622	92,537 +3.7%	97.92	US$4,895,622